RAFAEL HOLDINGS, INC. Accumulated Other Comprehensive Income
RAFAEL HOLDINGS, INC. (RFL) had Accumulated Other Comprehensive Income of $3.93 million as of 2022-01-31, per its 10-Q filed 2022-03-17.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2022-03-17
- 2022-01-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $3.93M.
- 2021-10-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $3.78M.
- 2021-07-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $3.77M.
- 2021-04-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $3.77M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2022-01-31 | $3.93M 10-Q · filed 2022-03-17 |
| 2021-10-31 | $3.78M 10-Q/A · filed 2022-02-28 |
| 2021-07-31 | $3.77M 10-Q · filed 2022-03-17 |
| 2021-04-30 | $3.77M 10-Q · filed 2021-06-14 |
| 2021-01-31 | $3.76M 10-Q · filed 2021-03-17 |
| 2020-10-31 | $3.72M 10-Q · filed 2020-12-15 |
| 2020-07-31 | $3.76M 10-K · filed 2021-10-18 |
| 2020-04-30 | $3.75M 10-Q · filed 2020-06-09 |
| 2020-01-31 | $3.76M 10-Q · filed 2020-03-05 |
| 2019-10-31 | $3.79M 10-Q · filed 2019-12-09 |
| 2019-07-31 | $3.78M 10-K · filed 2020-10-29 |
| 2019-04-30 | $4.13M 10-Q · filed 2019-06-05 |
| 2019-01-31 | $4.08M 10-Q · filed 2019-03-12 |
| 2018-10-31 | $4.16M 10-Q · filed 2018-12-10 |
| 2018-07-31 | $4.04M 10-K · filed 2019-10-04 |
| 2018-04-30 | $2.00M 10-Q · filed 2018-06-11 |
| 2018-01-31 | $2.39M 10-Q · filed 2018-03-12 |
| 2017-07-31 | $2.32M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |